Stay updated on Tezepelumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tezepelumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Tezepelumab in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedAn NIH grant/contract note for 2018 was added. The page revision stamp was updated to v3.6.6, replacing the previous version v3.6.5.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange Detected- The page revision has been updated from v3.6.4 to v3.6.5, indicating a routine maintenance release. This update does not modify core content or user-facing functionality; it serves as a backend version bump for the page.SummaryDifference0.0%

- Check37 days agoChange DetectedThe location entry for Zaporizhzhia, Ukraine (69000) has been updated to Zaporizhzhya, Ukraine (69000) in the study's locations list, reflecting a transliteration/name update.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, representing a newer release of the page's content/assets. This indicates an update to the site’s underlying code/assets.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, indicating a minor behind-the-scenes update; no study content changes are indicated.SummaryDifference0.0%

- Check80 days agoChange DetectedRecruitment status shows no longer looking for participants, indicating enrollment has ended. New sections provide guidance (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated.SummaryDifference0.3%

Stay in the know with updates to Tezepelumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Atopic Dermatitis Clinical Trial page.